Quick Answer
Cordyceps Sunshine Biotech Holdings Co., Ltd. reported Stockholders Equity of -$375.5 thousand for the year ending 2024.
- Cordyceps Sunshine Biotech Holdings Co., Ltd. showed a decrease of -147.4% in Stockholders Equity from 2023 to 2024.
- This data is from Cordyceps Sunshine Biotech Holdings Co., Ltd.'s annual report (Form 10-K), filed with the SEC on June 13, 2025.
- XBRL data for this metric is available from 2020 to 2024 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 5 years of available data (2020 to 2024), Cordyceps Sunshine Biotech Holdings Co., Ltd.'s Stockholders Equity has declined by 2,831.2%.
- Historical annual values: Fiscal year 2024: -$375.5 thousand | Fiscal year 2023: -$151.8 thousand | Fiscal year 2022: -$951.3 thousand | Fiscal year 2021: -$275.8 thousand | Fiscal year 2020: -$12.8 thousand.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: